Skip to main content

Table 3 Multivariate analysis for OS

From: Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

 

P Value

95% CI

Lower

Upper

Bevacizumab administration

.134

.309

1.169

ECOG score

.271

719

3.231

Surgery

.008

1.287

5.201

Age > 65

.732

.632

1.921

NLR

.569

.632

2.302

FIGO stage

.784

.859

1.122

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us